Editorial Board

Editor-in-Chief

  • J. R. Guyton, Duke University Medical Center, Durham, North Carolina, United States of America

Associate Editors

  • W. E. Boden, VA New England Healthcare System, Bedford, Massachusetts, United States of America, Section Specialty - Epidemiology,  Clinical trials,  and Preventive Cardiology
  • E.A. Brinton, Utah Foundation for Biomedical Research, Atherometabolic Research, Salt Lake City, Utah, United States of America, Section Specialty: Lipidology
  • W.V. Brown, Emory University, Atlanta, Georgia, United States of America, Section Specialty: Lipoprotein Metabolism and Clinical Lipidology
  • A. Cuevas, Centro Avanzado de Medicina Metabólica y Nutrición, Santiago, Chile, Section Specialty: Obesity,  Nutrition,  Atherosclerosis,  and Dislipidemias
  • M. Davidson, University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States of America, Section Specialty: Clinical Trials
  • D. DeSilvey, Northern Light Blue Hill Memorial Hospital, Blue Hill, Maine, United States of America, Section Specialty: Cardiovascular Medicine
  • D. L. Dixon, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, United States of America, Section Specialty: Pharmacotherapy,  Cardiometabolic Disease,  and Health Outcomes Research
  • P.B. Duell, Oregon Health & Science University, Portland, Oregon, United States of America, Section Specialty: Endocrinology and diabetes,  Preventive Cardiology
  • J. Falko, University of Colorado Division of Endocrinology Metabolism & Diabetes, Aurora, Colorado, United States of America, Section Specialty: Endocrinology,  Metabolism & Diabetes
  • D. Gaudet, University of Montreal, Montréal, Québec, Canada, Section Specialty: Hypertriglyceridemia,  Genetic Lipid Disorders,  Cardiometabolic Risk
  • E. Gill, University of Washington, Seattle, Washington, United States of America, Section Specialty: Cardiology
  • I.J. Goldberg, NYU Langone Health, New York, New York, United States of America, Section Specialty: Basic Lipid Physiology,  Lipolytic Enzymes
  • R.A. Hegele, Western University, London, Ontario, Canada, Genetics, Lipids, Hypercholesterolemia, Hypertriglyceridemia, Atherosclerosis
  • L. Hemphill, MASSACHUSETTS GENERAL HOSP, Boston, Massachusetts, United States of America, Section Specialty: Clinical Trials,  Familial hypercholesterolemia,  LDL apheresis
  • M. Ito, Oregon Health & Science University, Portland, Oregon, United States of America, Section Specialty: Pharmacology,  Clinical Lipidology,  Familial hypercholesterolemia
  • T. Jacobson, Emory University, Atlanta, Georgia, United States of America, Section Specialty: Epidemiology,  Disease Prevention,  Clinical Trials
  • W.G. Jerome, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America, Section Specialty: Pathology,  Microbiology,  and Immunology
  • P. Jones, Baylor College of Medicine, Houston, Texas, United States of America, Section Specialty: Lipidology,  Atheroclerosis
  • D. Kalra, University of Louisville, Louisville, Kentucky, United States of America, Section Specialty: Risk Assessment,  High-risk Populations,  Guidelines,  Atherosclerosis Imaging
  • W. Karmally, Columbia University Irving Medical Center, New York, New York, United States of America, Section Specialty: Women and Heart disease,  Prevention Cardiology,  Nutrition
  • R.M. Krauss, Children's Hospital Oakland Research Institute, Oakland, California, United States of America, Section Specialty: Endocrinology and Metabolism
  • P. Kris-Etherton, The Pennsylvania State University, University Park, Pennsylvania, United States of America, Section Specialty,  Nutrition Science/Dietetics
  • R. La Forge, Duke University Hospital, Durham, North Carolina, United States of America, Section Specialty: Cardiac Rehabilitation,  Metabolism,  Nutrition,  Lifestyle
  • B. Lamarche, Laval University, Québec, Quebec, Canada, Section Specialty: Nutrition,  Dietary intervention,  Epidemiology
  • E. Lerma, University of Illinois Chicago College of Medicine, Chicago, Illinois, United States of America
  • M. Lopes-Virella, Medical University of South Carolina, Department of Medicine, Charleston, South Carolina, United States of America, Section Specialty: Diabetes & Immunology
  • R.H. Mackey, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Section Specialty: Epidemiology
  • M.J. Malloy, University of California San Francisco, San Francisco, California, United States of America, Section Specialty: Pediatric Lipidology,  Genetics,  Lipoproteins
  • S.S. Martin, Johns Hopkins Hospital and Health System, Baltimore, Maryland, United States of America, Digital health,  Precision medicine,  Lipidology,  LDL cholesterol
  • J. Plutzky, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Section Specialty: Cardiovascular Disease,  Lipid Disorders,  Vascular Medicine
  • G. Pokrywka, Baltimore Lipid Center, Towson, Maryland, United States of America, Section Specialty: Clinical Lipidology,  Advanced Lipid Protein Testing,  Women's Health and Menopause
  • A.T. Remaley, National Institutes of Health, Bethesda, Maryland, United States of America, ABC transporter,  cardiovascular disease,  lipoprotein metabolism
  • A. Rohatgi, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
  • R. Santos, University of Sao Paulo Heart Institute, SAO PAULO, Brazil, Familial Hypercholesterolemia,  Imaging in Atherosclerosis,  Preventive Cardiology
  • D. Soffer, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
  • P. Toth, University of Illinois Chicago College of Medicine at Peoria, Peoria, Illinois, United States of America, Section Specialty: Lipidology,  Preventive Cardiology
  • G. L. Vega, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Lipidology,  Obesity
  • K. Vijayaraghavan, The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, United States of America, Section Specialty: Lipidology,  Heart Failure,  Diabetes and Cardiorenal Connectome
  • S.S. Virani, Baylor College of Medicine, Houston, Texas, United States of America, Section Specialty: Cardiovascular Outcomes and Guidelines
  • G. Watts, The University of Western Australia, Perth, Western Australia, Australia,  Lipids,  Familial hypercholesterolaemia,  Lp(a),  Inherited heart disease,  Obesity,  Metabolism
  • A.S. Wierzbicki, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, Section Specialty: Cardiology,  Internal Medicine,  Diabetology
  • R. A. Wild, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
  • D. Wilson, Phoenix Children's Hospital, Phoenix, Arizona, United States of America, Section Speciality: Pediatric Lipid Management

Editorial Board

  • N. Abate, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
  • M. Al-Mallah, Henry Ford Heart and Vascular Institute Cardiology Heart Care, Detroit, Michigan, United States of America
  • E. Alhaj, WESTSIDE MEDICAL CENTER, Louisville, Kentucky, United States of America
  • H. Bays, Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, United States of America
  • R. C. Block, University of Rochester Medical Center, Department of Public Health Sciences, Rochester, New York, United States of America
  • M. B. Boffa, Western University, London, Ontario, Canada
  • M. Bottorff, University of Charleston School of Pharmacy, Charleston, West Virginia, United States of America
  • L. Braun, Rush University Medical Center, Chicago, Illinois, United States of America
  • H. Contois, Sun Diagnostics, New Gloucester, Maine, United States of America
  • W. Cromwell, Presbyterian Cardiovascular Institute, Dept. of Atherosclerosis and Lipoprotein Disorders, Charlotte, North Carolina, United States of America
  • J. Freeman, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, United States of America
  • S.A. Geraci, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
  • R.B. Goldberg, University of Miami School of Medicine, Miami, Florida, United States of America
  • A. Gotto Jr., Weill Cornell Medicine, New York, New York, United States of America
  • D. Karalis, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
  • K. Maki, MB Clinical Research and Consulting LLC, Addison, Illinois, United States of America
  • C. McNeal, Baylor Scott & White Neuroscience Institute, Temple, Texas, United States of America
  • D. Meyers, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
  • M. Miller, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
  • P. Moriarty, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
  • P. Morris, Medical University of South Carolina, Charleston, South Carolina, United States
  • A. Nafziger, Bassett Healthcare, Cooperstown, New York, United States of America
  • S. Nash, Esperion Therapeutics Inc, Ann Arbor, Michigan, United States of America
  • S. B. Patel, University of Cincinnati, Cincinnati, Ohio, United States of America
  • D. Rader, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
  • V. Raghavan, The Ohio State University, Columbus, Ohio, United States of America
  • M. Richman, The Center for Cholesterol Management, Los Angeles, California, United States of America
  • G. Ruotolo, Eli Lilly and Company, Indianapolis, Indiana, United States of America
  • F. Sacks, Harvard University T H Chan School of Public Health, Boston, Massachusetts, United States of America
  • M. Shapiro, Oregon Health & Science University, Portland, Oregon, United States of America
  • S. Shurmur, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
  • D.A. Smith, Mount Sinai Medical Center, New York, New York, United States of America
  • M. Sweeney, Emory University School of Medicine, Atlanta, Georgia, United States of America
  • J. Underberg, CareMount Medical Internal Medicine Department, New York, New York, United States of America
  • R. Vicari, Mima Century Research Associates, Melbourne, Florida, United States of America
  • G. Warnick, Berkeley HeartLab Inc, South San Francisco, California, United States of America
  • P. Weinstock, Cooper University Health Care, Camden, New Jersey, United States of America
  • P. Wilson, Emory University, Atlanta, Georgia, United States of America
  • M. Zema, Stony Brook University, Department of Medicine, New York, New York, United States of America
  • P. Ziajka, Florida Lipid Institute, Winter Park, Florida, United States of America
  • Z. Zineh, University of Florida College of Pharmacy, Gainesville, Florida, United States of America

Managing Editor